Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal Polyps.
Saved in:
| Title: | Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal Polyps. |
|---|---|
| Authors: | Peters A; Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Zhao X; IQVIA, Durham, NC, USA., Near AM; IQVIA, Durham, NC, USA., Han J; Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USA., Spahn JD; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA., Wu SS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA., Lindsley AW; US Medical Affairs, Amgen, Thousand Oaks, CA, USA., Le TT; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA., Wang EJ; IQVIA, Durham, NC, USA., Tuly R; IQVIA, Durham, NC, USA., Lee I; IQVIA, Durham, NC, USA., Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA. chris.ambrose@astrazeneca.com.; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA. chris.ambrose@astrazeneca.com. |
| Source: | Advances in therapy [Adv Ther] 2025 Apr; Vol. 42 (4), pp. 1783-1799. Date of Electronic Publication: 2025 Feb 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39969781 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal Polyps. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Peters+A%22">Peters A</searchLink>; Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Zhao+X%22">Zhao X</searchLink>; IQVIA, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Near+AM%22">Near AM</searchLink>; IQVIA, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Han+J%22">Han J</searchLink>; Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.<br /><searchLink fieldCode="AU" term="%22Spahn+JD%22">Spahn JD</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Wu+SS%22">Wu SS</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Lindsley+AW%22">Lindsley AW</searchLink>; US Medical Affairs, Amgen, Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Le+TT%22">Le TT</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Wang+EJ%22">Wang EJ</searchLink>; IQVIA, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Tuly+R%22">Tuly R</searchLink>; IQVIA, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Lee+I%22">Lee I</searchLink>; IQVIA, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ambrose+CS%22">Ambrose CS</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA. chris.ambrose@astrazeneca.com.; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA. chris.ambrose@astrazeneca.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2025 Apr; Vol. 42 (4), pp. 1783-1799. <i>Date of Electronic Publication: </i>2025 Feb 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39969781 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12325-025-03120-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1783 Titles: – TitleFull: Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal Polyps. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Peters A – PersonEntity: Name: NameFull: Zhao X – PersonEntity: Name: NameFull: Near AM – PersonEntity: Name: NameFull: Han J – PersonEntity: Name: NameFull: Spahn JD – PersonEntity: Name: NameFull: Wu SS – PersonEntity: Name: NameFull: Lindsley AW – PersonEntity: Name: NameFull: Le TT – PersonEntity: Name: NameFull: Wang EJ – PersonEntity: Name: NameFull: Tuly R – PersonEntity: Name: NameFull: Lee I – PersonEntity: Name: NameFull: Ambrose CS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2025 Apr Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1865-8652 Numbering: – Type: volume Value: 42 – Type: issue Value: 4 Titles: – TitleFull: Advances in therapy Type: main |
| ResultId | 1 |